BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24356758)

  • 1. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity.
    Peirovifar A; Gharehbaghi MM; Gharabaghi PM; Sadeghi K
    Singapore Med J; 2013 Dec; 54(12):709-12. PubMed ID: 24356758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
    Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
    Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity.
    Gharehbaghi MM; Peirovifar A; Sadeghi K; Mostafidi H
    Indian J Ophthalmol; 2012; 60(6):527-30. PubMed ID: 23202391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
    Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
    Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.
    Hellström A; Engström E; Hård AL; Albertsson-Wikland K; Carlsson B; Niklasson A; Löfqvist C; Svensson E; Holm S; Ewald U; Holmström G; Smith LE
    Pediatrics; 2003 Nov; 112(5):1016-20. PubMed ID: 14595040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.
    Kong L; Bhatt AR; Demny AB; Coats DK; Li A; Rahman EZ; Smith OE; Steinkuller PG
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):956-61. PubMed ID: 25613938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity.
    Yenice O; Cerman E; Ashour A; Firat R; Haklar G; Sirikci O; Akman I; Kazokoglu H
    Ophthalmic Surg Lasers Imaging Retina; 2013 Nov; 44(6):549-54. PubMed ID: 24221462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy of prematurity and serum level of insulin-like growth factor-1.
    Banjac L; Bokan V
    Acta Clin Croat; 2012 Jun; 51(2):209-13. PubMed ID: 23115944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Serum Levels of Asymmetric Dimethylarginine, Vascular Endothelial Growth Factor, and Insulin-Like Growth Factor-1 in Preterms with Retinopathy of Prematurity.
    Aydoğan S; Dilli D; Kabataş EU; Akduman H; Şah Ipek M; Oğuz B; Ataş N; Zenciroğlu A
    Fetal Pediatr Pathol; 2022 Aug; 41(4):634-639. PubMed ID: 34289792
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity.
    Machalinska A; Modrzejewska M; Kotowski M; Dziedziejko V; Kucia M; Kawa M; Safranow K; Baskiewicz-Masiuk M; Modrzejewska A; Karczewicz D; Rudnicki J; Machalinski B
    Arch Ophthalmol; 2010 Oct; 128(10):1311-9. PubMed ID: 20938001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLASMA CONCENTRATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB INJECTION.
    Hong YR; Kim YH; Kim SY; Nam GY; Cheon HJ; Lee SJ
    Retina; 2015 Sep; 35(9):1772-7. PubMed ID: 25829347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP)].
    Villegas-Becerril E; González-Fernández R; Perula-Torres L; Gallardo-Galera JM
    Arch Soc Esp Oftalmol; 2006 Nov; 81(11):641-6. PubMed ID: 17136637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential contribution of mobilized circulating endothelial progenitor cells to development of retinal neovascularization in preterm infants with ROP.
    Machalińska A; Modrzejewska M; Kawa M; Paczkowska E; Dziedziejko V; Safranow K; Lubiński W; Machaliński B
    Klin Oczna; 2013; 115(3):194-8. PubMed ID: 24745090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
    Hellgren G; Löfqvist C; Hård AL; Hansen-Pupp I; Gram M; Ley D; Smith LE; Hellström A
    Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity.
    Hellgren G; Löfqvist C; Hansen-Pupp I; Gram M; Smith LE; Ley D; Hellström A
    Growth Horm IGF Res; 2018 Apr; 39():19-24. PubMed ID: 29274846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity.
    Cekmez F; Pirgon O; Aydemir G; Dundar B; Cekmez Y; Karaoglu A; Fidanc K; Tunc T; Aydinoz S; Karademir F; Süleymanoglu S
    Biomark Med; 2012 Dec; 6(6):821-5. PubMed ID: 23227848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of WINROP for detecting retinopathy of prematurity in a North American cohort of preterm infants.
    Jung JL; Wagner BD; McCourt EA; Palestine AG; Cerda A; Cao JH; Enzenauer RW; Singh JK; Braverman RS; Wymore E; Lynch AM
    J AAPOS; 2017 Jun; 21(3):229-233. PubMed ID: 28506724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab.
    Zhou Y; Jiang Y; Bai Y; Wen J; Chen L
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):31-6. PubMed ID: 25851862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.